Kythera files for IPO

Kythera Biopharmaceuticals Inc. (Calabasas, Calif.) proposed to raise $86.3 million in an IPO underwritten by JPMorgan; Goldman Sachs; Leerink; and Lazard. Kythera's ATX-101 is in Phase III testing to...